Tag: Chirinjeev Kathuria
SEC filing of the week: Ocean Biomedical faces loss of licensing...
PROVIDENCE – Ocean Biomedical Inc. is facing the termination of licensing agreements for technologies developed at Brown University and Rhode Island Hospital.
In its filing...
SEC filing of the week: Ocean Biomedical expands into energy, digital...
PROVIDENCE – Ocean Biomedical Inc. is expanding into the energy and digital-asset sectors while announcing it has been delisted on the Nasdaq Stock Market...
SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M...
PROVIDENCE – Ocean Biomedical Inc. ended 2024 with a loss of $9.4 million compared to the $114.4 million deficit the company reported the year...
Ocean Biomedical faces Nasdaq delisting
PROVIDENCE – Ocean Biomedical Inc. is at risk of being kicked off the Nasdaq exchange for failing to file quarterly and other required financial...
Ocean Biomedical reports ‘highly compelling’ results in first clinical trial
PROVIDENCE – Ocean Biomedical Inc., working with joint venture partner Virion Therapeutics LLC, said earlier this month that it saw positive results in its...
Ocean Biomedical enters first in-human clinical trial
PROVIDENCE – Ocean Biomedical, a biopharmaceutical company launched out of Brown University, is entering its first in-human clinical trial with Virion Therapeutics LLC, a...
Ocean Biomedical hopes to raise $22M going public
PROVIDENCE – Ocean Biomedical Inc. hopes to raise up to $22 million in an amended initial public offering filed with Securities and Exchange Commission...
- Featured Event -
